{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:54Z","timestamp":1759333254612},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T00:00:00Z","timestamp":1299974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00280-011-1599-7","type":"journal-article","created":{"date-parts":[[2011,3,12]],"date-time":"2011-03-12T02:16:26Z","timestamp":1299896186000},"page":"1155-1159","source":"Crossref","is-referenced-by-count":12,"title":["Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"68","author":[{"given":"Meryem","family":"Albayrak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uljan","family":"Konyssova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhre","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turkiz","family":"Gursel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sezen","family":"Guntekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Ferda","family":"Percin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulker","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,13]]},"reference":[{"key":"1599_CR1","first-page":"651","volume":"32","author":"RM Weinshilboum","year":"1980","unstructured":"Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651\u2013662","journal-title":"Am J Hum Genet"},{"key":"1599_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/157488406784111627","volume":"1","author":"S Zhou","year":"2006","unstructured":"Zhou S (2006) Clinical pharmacogenomics of thiopurine S-methyltransferase. Curr Clin Pharmacol 1:119\u2013128","journal-title":"Curr Clin Pharmacol"},{"key":"1599_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2009.11.014","volume":"24","author":"R Pieters","year":"2010","unstructured":"Pieters R, Carroll WL (2010) Biology and treatment of acute lymphoblastic leukemia. Hematol Oncol Clin N Am 24:1\u201318","journal-title":"Hematol Oncol Clin N Am"},{"key":"1599_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1994.4","volume":"55","author":"HL McLeod","year":"1994","unstructured":"McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE (1994) Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 55:15\u201320","journal-title":"Clin Pharmacol Ther"},{"key":"1599_CR5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/0003-4819-126-8-199704150-00003","volume":"126","author":"CR Yates","year":"1997","unstructured":"Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE (1997) Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathiopurine and mercaptopurine intolerance. Ann Intern Med 126:608\u2013614","journal-title":"Ann Intern Med"},{"key":"1599_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/pgs.09.155","volume":"11","author":"JE Higgs","year":"2010","unstructured":"Higgs JE, Payne K, Roberts C, Newman WG (2010) Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications. Pharmacogenomics 11:177\u2013188","journal-title":"Pharmacogenomics"},{"key":"1599_CR7","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/jnci\/91.23.2001","volume":"91","author":"MV Relling","year":"1999","unstructured":"Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, Pui CH, Evans WE (1999) Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 91:2001\u20132008","journal-title":"J Natl Cancer Inst"},{"key":"1599_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/FPC.0b013e3283097328","volume":"18","author":"S Ujiie","year":"2008","unstructured":"Ujiie S, Sasaki T, Mizugaki M, Ishikawa M, Hiratsuka M (2008) Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2\u2013*24). Pharmacogenet Genomics 18:887\u2013893","journal-title":"Pharmacogenet Genomics"},{"key":"1599_CR9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jmb.2008.04.032","volume":"379","author":"K Rutherford","year":"2008","unstructured":"Rutherford K, Daggett V (2008) Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics. J Mol Biol 379:803\u2013814","journal-title":"J Mol Biol"},{"key":"1599_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00043426-200206000-00002","volume":"24","author":"WE Evans","year":"2002","unstructured":"Evans WE (2002) Comprehensive assessment of thiopurine S-methyltransferase (TPMT) alleles in three ethnic populations. J Pediatr Hematol Oncol 24:335\u2013336","journal-title":"J Pediatr Hematol Oncol"},{"key":"1599_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-004-0732-5","volume":"60","author":"C Ganiere-Monteil","year":"2004","unstructured":"Ganiere-Monteil C, Medard Y, Lejus C, Bruneau B, Pineau A, Fenneteau O, Bourin M, Jacqz-Aigrain E (2004) Phenotype, genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur J Clin Pharmacol 60:89\u201396","journal-title":"Eur J Clin Pharmacol"},{"key":"1599_CR12","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2217\/pgs.09.103","volume":"10","author":"L Serpe","year":"2009","unstructured":"Serpe L, Calvo PL, Muntoni E, D\u2019Antico S, Giaccone M, Avagnina A, Baldi M, Barbera C, Curti F, Pera A et al (2009) Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian-Caucasian population: differences in enzyme activity. Pharmacogenomics 10:1753\u20131765","journal-title":"Pharmacogenomics"},{"key":"1599_CR13","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1007\/s10620-006-9119-z","volume":"52","author":"JP Gisbert","year":"2007","unstructured":"Gisbert JP, Gomollon F, Cara C, Luna M, Gonzalez-Lama Y, Pajares JM, Mate J, Guijarro LG (2007) Thiopurine methyltransferase activity in Spain: a study of 14,545 patients. Dig Dis Sci 52:1262\u20131269","journal-title":"Dig Dis Sci"},{"key":"1599_CR14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/01.ftd.0000249947.17676.92","volume":"28","author":"L Dokmanovic","year":"2006","unstructured":"Dokmanovic L, Urosevic J, Janic D, Jovanovic N, Petrucev B, Tosic N, Pavlovic S (2006) Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Ther Drug Monit 28:800\u2013806","journal-title":"Ther Drug Monit"},{"key":"1599_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00228-008-0590-7","volume":"65","author":"E Efrati","year":"2009","unstructured":"Efrati E, Adler L, Krivoy N, Sprecher E (2009) Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population. Eur J Clin Pharmacol 65:257\u2013262","journal-title":"Eur J Clin Pharmacol"},{"key":"1599_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00228-007-0426-x","volume":"64","author":"SK Kham","year":"2008","unstructured":"Kham SK, Soh CK, Liu TC, Chan YH, Ariffin H, Tan PL, Yeoh AE (2008) Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol 64:373\u2013379","journal-title":"Eur J Clin Pharmacol"},{"key":"1599_CR17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pbc.21837","volume":"52","author":"EV Samochatova","year":"2009","unstructured":"Samochatova EV, Chupova NV, Rudneva A, Makarova O, Nasedkina TV, Fedorova OE, Glotov AS, Kozhekbaeva Z, Maiorova OA, Roumyantsev AG et al (2009) TPMT genetic variations in populations of the Russian Federation. Pediatr Blood Cancer 52:203\u2013208","journal-title":"Pediatr Blood Cancer"},{"key":"1599_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00008571-200104000-00011","volume":"11","author":"M Ando","year":"2001","unstructured":"Ando M, Ando Y, Hasegawa Y, Sekido Y, Shimokata K, Horibe K (2001) Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukemia. Pharmacogenetics 11:269\u2013273","journal-title":"Pharmacogenetics"},{"key":"1599_CR19","first-page":"500","volume":"129","author":"G Kapoor","year":"2009","unstructured":"Kapoor G, Maitra A, Brahmachari S, Brahmachari V (2009) Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphisms. Indian J Med Res 129:500\u2013505","journal-title":"Indian J Med Res"},{"key":"1599_CR20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/hmg\/8.2.367","volume":"8","author":"MM Ameyaw","year":"1999","unstructured":"Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, McLeod HL (1999) Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 8:367\u2013370","journal-title":"Hum Mol Genet"},{"key":"1599_CR21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/08880010701441286","volume":"24","author":"Z Kaya","year":"2007","unstructured":"Kaya Z, Gursel T, Bakkaloglu SA, Kocak U, Atasever T, Oktar SO (2007) Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol 24:257\u2013267","journal-title":"Pediatr Hematol Oncol"},{"key":"1599_CR22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ajh.20947","volume":"82","author":"TB Tumer","year":"2007","unstructured":"Tumer TB, Ulusoy G, Adali O, Sahin G, Gozdasoglu S, Arinc E (2007) The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia. Am J Hematol 82:906\u2013910","journal-title":"Am J Hematol"},{"key":"1599_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10915810601118222","volume":"26","author":"AO Ada","year":"2007","unstructured":"Ada AO, Suzen HS, Iscan M (2007) Polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1 in a male Turkish population. Int J Toxicol 26:41\u201346","journal-title":"Int J Toxicol"},{"key":"1599_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/cbf.1222","volume":"23","author":"M Aydin","year":"2005","unstructured":"Aydin M, Hatirnaz O, Erensoy N, Ozbek U (2005) CYP2D6 and CYP1A1 mutations in the Turkish population. Cell Biochem Funct 23:133\u2013135","journal-title":"Cell Biochem Funct"},{"key":"1599_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2125.1997.t01-1-00607.x","volume":"44","author":"L Lennard","year":"1997","unstructured":"Lennard L, Welch JC, Lilleyman JS (1997) Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. Br J Clin Pharmacol 44:455\u2013461","journal-title":"Br J Clin Pharmacol"},{"key":"1599_CR26","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.293.12.1485","volume":"293","author":"M Stanulla","year":"2005","unstructured":"Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M, Welte K, Ludwig WD, Bartram CR, Zanger UM, Eichelbaum M, Schrappe M, Schwab M (2005) Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 293:1485\u20131489","journal-title":"JAMA"},{"key":"1599_CR27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/beha.2002.0225","volume":"15","author":"CH Pui","year":"2002","unstructured":"Pui CH, Relling MV, Evans WE (2002) Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 15:741\u2013756","journal-title":"Best Pract Res Clin Haematol"},{"key":"1599_CR28","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","volume":"93","author":"MV Relling","year":"1999","unstructured":"Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE (1999) Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93:2817\u20132823","journal-title":"Blood"},{"key":"1599_CR29","first-page":"321","volume":"27","author":"C Tani","year":"2009","unstructured":"Tani C, Mosca M, Colucci R, Gori G, d\u2019Ascanio A, Ghisu N, Fornai M, Di Paolo A, Blandizzi C, Del Tacca M et al (2009) Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases. Clin Exp Rheumatol 27:321\u2013324","journal-title":"Clin Exp Rheumatol"},{"key":"1599_CR30","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1111\/j.1572-0241.2006.00843.x","volume":"101","author":"JP Gisbert","year":"2006","unstructured":"Gisbert JP, Nino P, Rodrigo L, Cara C, Guijarro LG (2006) Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients. Am J Gastroenterol 101:2769\u20132776","journal-title":"Am J Gastroenterol"},{"key":"1599_CR31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2710.2006.00775.x","volume":"31","author":"DK Song","year":"2006","unstructured":"Song DK, Zhao J, Zhang LR (2006) TPMT genotype and its clinical implication in renal transplant recipients with azathiopurine treatment. J Clin Pharm Ther 31:627\u2013635","journal-title":"J Clin Pharm Ther"},{"key":"1599_CR32","first-page":"243","volume":"33","author":"JK Rees","year":"1990","unstructured":"Rees JK, Gray RG (1990) Remission induction and post remission therapy in acute myelogenous leukemia. Haematol Blood Transfus 33:243\u2013248","journal-title":"Haematol Blood Transfus"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-011-1599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-011-1599-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-011-1599-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T08:19:55Z","timestamp":1592381995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-011-1599-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,13]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1599"],"URL":"https:\/\/doi.org\/10.1007\/s00280-011-1599-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,13]]}}}